Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 30
Page 730
... racemate . It also met this allegation with a conditional application to amend to make it clear that it did not claim any racemates or enantiomers as part of any racemates . This application was opposed . Claims 1 , 3 and 6 were alleged ...
... racemate . It also met this allegation with a conditional application to amend to make it clear that it did not claim any racemates or enantiomers as part of any racemates . This application was opposed . Claims 1 , 3 and 6 were alleged ...
Page 763
... racemate in preference to a pure enantiomer , or the reverse , it should be justified by the submission of appropriate data . He pointed out that the FDA guidelines noted that even in racemates , enantiomers might be considered as ...
... racemate in preference to a pure enantiomer , or the reverse , it should be justified by the submission of appropriate data . He pointed out that the FDA guidelines noted that even in racemates , enantiomers might be considered as ...
Page 764
... racemate . But by 1985 Eli - Lilly had resolved the racemate and found that ( + ) isomer was slightly more potent than the ( − ) isomer . Venlafaxine was a racemate first introduced by Wyeth in 1993. However , by December 1983 Wyeth ...
... racemate . But by 1985 Eli - Lilly had resolved the racemate and found that ( + ) isomer was slightly more potent than the ( − ) isomer . Venlafaxine was a racemate first introduced by Wyeth in 1993. However , by December 1983 Wyeth ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy